Clinical Trial

A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.
Trial Details
NCT Number NCT07716410
Lead Sponsor Novartis Pharmaceuticals
Conditions Cryptosporidiosis
Enrollment 30 participants
Start Date 2026-01-09
Primary Completion 2027-05-19 (estimated)
Study Completion 2027-05-19 (estimated)
Updated on ClinicalTrials.gov 2026-07-21